🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, single-dose, placebo-controlled, 5-peri...
Status
Completed
Location
Research Site
Start Date
2017-12-15
Trial ID
NCT03364608
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multicenter, parall...
Status
Completed
Location
Research Site
Start Date
2019-03-20
Trial ID
NCT03847896
Treatments Being Tested
This is a randomised, placebo-controlled, double-blinded, multi-centre, 2-p...
Status
Terminated
Location
Research Site
Start Date
2021-03-12
Trial ID
NCT04643158
The purpose of this study is to compare the effect of budesonide/albuterol ...
Status
Recruiting
Location
Research Site
Start Date
2024-05-20
Trial ID
NCT06307665
This study has been designed to provide a substantial evidence of acute bro...
Status
Completed
Location
Unit of Preventive and Occupational Medicine - Laboratory of Respiratory Pathophysiology, University Hospital San Martino
Start Date
2010-04
Trial ID
NCT01112241
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of oral/lo...
Status
Unknown
Location
Multiple Locations
Start Date
2017-03
Trial ID
NCT03038295
Treatments Being Tested
This study will evaluate the dose response relationship among four doses of...
Status
Completed
Location
Novartis Investigator site
Start Date
2007-10
Trial ID
NCT00557466
Treatments Being Tested
To compare the pharmacokinetics of budesonide delivered by BDA MDI to budes...
Status
Completed
Location
IPS Research
Start Date
2021-05-06
Trial ID
NCT04848662
Treatments Being Tested
This is a randomized, cumulative dose, open-label, 2-period crossover, mult...
Status
Completed
Location
Research Site
Start Date
2017-12-29
Trial ID
NCT03371459
The purpose of this Phase III, multicentre, randomized, double-blind, singl...
Status
Completed
Location
Research Site
Start Date
2023-12-22
Trial ID
NCT06245551
Treatments Being Tested